Compare Franklin Resources, Inc. (BEN) vs Canopy Growth Corp (CGC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Franklin Resources, Inc. vs Canopy Growth Corp — how do they compare? Franklin Resources, Inc. trades at $33.37 (market cap $16.95B), while Canopy Growth Corp trades at $1 (market cap $421.10M). The key difference: Franklin Resources, Inc. is far larger — about 40.3× Canopy Growth Corp's market cap, and Franklin Resources, Inc. pays a 3.96% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| BEN | CGC | |
|---|---|---|
Market Cap | $16.95B | $421.10M |
Sector | Financials | Health |
52-Week High | $35.77 | $1.92 |
52-Week Low | $21.18 | $0.86 |
Enterprise Value | $29.90B | $378.55M |
Dividend Yield | 3.96% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Franklin Resources, Inc.
Franklin Resources provides investment services for individual and institutional investors. At the end of August 2022, Franklin had $1.388 trillion in managed assets, composed primarily of equity (32%), fixed-income (38%), multi-asset/balanced (10%) funds, alternatives (16%), and money market funds (4%). Distribution tends to be weighted more toward retail investors (49% of AUM) investors, as opposed to institutional (49%) and high-net-worth (2%) clients. Franklin is also one of the more global firms of the U.S.-based asset managers with more than 35% of its AUM invested in global/international strategies and 25% of managed assets sourced from clients domiciled outside the United States.
Read more on BEN →About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →
